A randomized placebo-controlled, Phase 1 pharmacokinetic/pharmacodynamic trial of AM-201 co-administration with olanzapine in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 15 Jan 2019
At a glance
- Drugs Betahistine (Primary) ; Olanzapine
- Indications Weight gain
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Proof of concept
- 15 Jan 2019 According to an Auris Medical media release, clinical trial application has been submitted and the company expects to start recruitment in this trial in first quarter of 2019.
- 20 Nov 2018 According to an Auris Medical media release, following the read-out from the study, the Company expects to file the IND application for AM-201 later in 2019.
- 17 Oct 2018 According to an Auris Medical media release, the trial is expected to start in the first quarter of 2019.